Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Alberto G Conti

6PUBLICATIONS

51CO-AUTHORS

Haematological tumoursPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTissue engineering

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jan 16, 2026

Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.

Alberto G Conti, Alexander C Evans, Teresa von Linde

|Mar 05, 2025

Aspirin prevents metastasis by limiting platelet TXA<sub>2</sub> suppression of T cell immunity.

Jie Yang, Yumi Yamashita-Kanemaru, Benjamin I Morris

|Feb 10, 2025

Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses.

Puspendu Sardar, Benjamin S Beresford-Jones, Wangmingyu Xia

|Jul 12, 2024

IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.

Charlotte J Imianowski, Paula Kuo, Sarah K Whiteside

|Dec 15, 2023

Acquisition of suppressive function by conventional T cells limits antitumor immunity upon T<sub>reg</sub> depletion.

Sarah K Whiteside, Francis M Grant, Giorgia Alvisi

|Apr 20, 2023

Orthogonal engineering of synthetic T cell states to enhance cancer immunotherapy.

Alberto G Conti, Rahul Roychoudhuri

Pageof 1

Frequent Collaborators

6 joint publications

Rahul Roychoudhuri

5 joint publications

Charlotte J Imianowski

5 joint publications

Alexander C Evans

4 joint publications

Jie Yang

4 joint publications

Klaus Okkenhaug

2 joint publications

Sarah K Whiteside

2 joint publications

Yumi Yamashita-Kanemaru

2 joint publications

Alexander J Wesolowski

2 joint publications

Layla Dahmani

2 joint publications

Teresa von Linde

Frequent Collaborators

6 joint publications

Rahul Roychoudhuri

5 joint publications

Charlotte J Imianowski

5 joint publications

Alexander C Evans

4 joint publications

Jie Yang

Top Related Videos

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on : Jan 17, 2025

See more related videos

Top Related Videos

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on : Jan 17, 2025

See more related videos